Nociceptinergic system as potential target in Parkinson's disease

K. Tekes, Saeed Tariq, Ernest Adeghate, Rudolf Laufer, Farzad Hashemi, Afshan Siddiq, H. Kalász

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Nociceptinergic system has become an important target for drug development since the identification of the "orphan", opioid-like-1 receptor and the isolation of its endogenous agonist nociceptin. Involvement of nociceptinergic system has been verified in a wide range of pathophysiological processes. A large number of nociceptinergic agonists and antagonists with peptide and non-peptide structures have been developed. Several non-peptide nociceptinergic antagonists have recently shown effective on different animal models of parkinsonism. Neuropharmacological background for antiparkinsonian effect of nociceptinergic antagonists, experimental models with high predictive value, nociceptinergic antagonists shown to have potential effect in Parkinson's disease are summarized. Medicinal chemistry data (logP and TPSA) of the NOP receptor antagonists which are found to be effective in animal models of Parkinson's disease are provided.

Original languageEnglish
Pages (from-to)1389-1397
Number of pages9
JournalMini-Reviews in Medicinal Chemistry
Volume13
Issue number10
DOIs
Publication statusPublished - 2013

Fingerprint

Parkinson Disease
Animal Models
Antiparkinson Agents
Pharmaceutical Chemistry
Parkinsonian Disorders
Opioid Analgesics
Theoretical Models
Peptides
Pharmaceutical Preparations
nociceptin

Keywords

  • Animal models of parkinson's disease
  • Antiparkinsonian effect
  • LogP
  • Medicinal chemistry data
  • Nop receptor antagonists
  • TPSA

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Nociceptinergic system as potential target in Parkinson's disease. / Tekes, K.; Tariq, Saeed; Adeghate, Ernest; Laufer, Rudolf; Hashemi, Farzad; Siddiq, Afshan; Kalász, H.

In: Mini-Reviews in Medicinal Chemistry, Vol. 13, No. 10, 2013, p. 1389-1397.

Research output: Contribution to journalArticle

Tekes, K. ; Tariq, Saeed ; Adeghate, Ernest ; Laufer, Rudolf ; Hashemi, Farzad ; Siddiq, Afshan ; Kalász, H. / Nociceptinergic system as potential target in Parkinson's disease. In: Mini-Reviews in Medicinal Chemistry. 2013 ; Vol. 13, No. 10. pp. 1389-1397.
@article{e60a4a997f8d47c3af25079e5cd180a4,
title = "Nociceptinergic system as potential target in Parkinson's disease",
abstract = "Nociceptinergic system has become an important target for drug development since the identification of the {"}orphan{"}, opioid-like-1 receptor and the isolation of its endogenous agonist nociceptin. Involvement of nociceptinergic system has been verified in a wide range of pathophysiological processes. A large number of nociceptinergic agonists and antagonists with peptide and non-peptide structures have been developed. Several non-peptide nociceptinergic antagonists have recently shown effective on different animal models of parkinsonism. Neuropharmacological background for antiparkinsonian effect of nociceptinergic antagonists, experimental models with high predictive value, nociceptinergic antagonists shown to have potential effect in Parkinson's disease are summarized. Medicinal chemistry data (logP and TPSA) of the NOP receptor antagonists which are found to be effective in animal models of Parkinson's disease are provided.",
keywords = "Animal models of parkinson's disease, Antiparkinsonian effect, LogP, Medicinal chemistry data, Nop receptor antagonists, TPSA",
author = "K. Tekes and Saeed Tariq and Ernest Adeghate and Rudolf Laufer and Farzad Hashemi and Afshan Siddiq and H. Kal{\'a}sz",
year = "2013",
doi = "10.2174/13895575113139990006",
language = "English",
volume = "13",
pages = "1389--1397",
journal = "Mini-Reviews in Medicinal Chemistry",
issn = "1389-5575",
publisher = "Bentham Science Publishers B.V.",
number = "10",

}

TY - JOUR

T1 - Nociceptinergic system as potential target in Parkinson's disease

AU - Tekes, K.

AU - Tariq, Saeed

AU - Adeghate, Ernest

AU - Laufer, Rudolf

AU - Hashemi, Farzad

AU - Siddiq, Afshan

AU - Kalász, H.

PY - 2013

Y1 - 2013

N2 - Nociceptinergic system has become an important target for drug development since the identification of the "orphan", opioid-like-1 receptor and the isolation of its endogenous agonist nociceptin. Involvement of nociceptinergic system has been verified in a wide range of pathophysiological processes. A large number of nociceptinergic agonists and antagonists with peptide and non-peptide structures have been developed. Several non-peptide nociceptinergic antagonists have recently shown effective on different animal models of parkinsonism. Neuropharmacological background for antiparkinsonian effect of nociceptinergic antagonists, experimental models with high predictive value, nociceptinergic antagonists shown to have potential effect in Parkinson's disease are summarized. Medicinal chemistry data (logP and TPSA) of the NOP receptor antagonists which are found to be effective in animal models of Parkinson's disease are provided.

AB - Nociceptinergic system has become an important target for drug development since the identification of the "orphan", opioid-like-1 receptor and the isolation of its endogenous agonist nociceptin. Involvement of nociceptinergic system has been verified in a wide range of pathophysiological processes. A large number of nociceptinergic agonists and antagonists with peptide and non-peptide structures have been developed. Several non-peptide nociceptinergic antagonists have recently shown effective on different animal models of parkinsonism. Neuropharmacological background for antiparkinsonian effect of nociceptinergic antagonists, experimental models with high predictive value, nociceptinergic antagonists shown to have potential effect in Parkinson's disease are summarized. Medicinal chemistry data (logP and TPSA) of the NOP receptor antagonists which are found to be effective in animal models of Parkinson's disease are provided.

KW - Animal models of parkinson's disease

KW - Antiparkinsonian effect

KW - LogP

KW - Medicinal chemistry data

KW - Nop receptor antagonists

KW - TPSA

UR - http://www.scopus.com/inward/record.url?scp=84881536769&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881536769&partnerID=8YFLogxK

U2 - 10.2174/13895575113139990006

DO - 10.2174/13895575113139990006

M3 - Article

C2 - 23701656

AN - SCOPUS:84881536769

VL - 13

SP - 1389

EP - 1397

JO - Mini-Reviews in Medicinal Chemistry

JF - Mini-Reviews in Medicinal Chemistry

SN - 1389-5575

IS - 10

ER -